Goggins Joins ZO Skin Health Board of Directors

ZO Skin Health has announced a new addition to its board of directors, following the October acquisition of a majority stake in the business by funds managed by Blackstone Tactical Opportunities.

Zo Skin Health Logo

ZO Skin Health has announced that Colleen Goggins is joining its board of directors. Goggins has served on the boards of TD Bank Group, Valeant Pharmaceuticals, Munich-based KraussMaffei Group and Zurich-based SIG Combibloc. 

"On behalf of ZO Skin Health's management team, we are excited to welcome Colleen as a new member on the board of directors, and know we will benefit from her experience, insights, relationships and leadership as we grow the business globally," said Mark Williams, president and CEO of ZO Skin Health.

ZO Skin Health was founded by Zein Obagi, MD, an industry leading dermatologist. The company continues to support his mission of providing healthy skin for all, regardless of age, ethnicity, unique skin condition or skin type, while utilizing the power of science to help pave the way for breakthroughs in skin care.

"I am thrilled to be joining the board of ZO Skin Health and excited to be working with the management team and Blackstone to help build ZO into the world's leading physician-dispensed skincare brand," said Goggins. 


More in News